CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
79,631,111
Share change
+2,076,622
Total reported value
$1,299,479,761
Put/Call ratio
188%
Price per share
$16.32
Number of holders
129
Value change
+$23,208,229
Number of buys
65
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q2 2014

As of 30 Jun 2014, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,631,111 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, OPPENHEIMER FUNDS INC, VANGUARD GROUP INC, COLUMBIA WANGER ASSET MANAGEMENT LLC, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., State Street Corp, and Bank of New York Mellon Corp. This page lists 129 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.